Friedreich's Ataxia Completed Phase 2 Trials for TAK-831 (DB16067)

Also known as: Friedreich Ataxia / Friedreich's ataxia (disorder)

IndicationStatusPhase
DBCOND0037758 (Friedreich's Ataxia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03214588Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich AtaxiaTreatment